In the early 1990’s, after the demise of the former Soviet Union, Russia and many other countries of the former Soviet Union found they no longer had available and affordable pharmaceuticals for their citizens. Under the former Soviet Union’s model for pharmaceutical manufacturing and distribution, a single government trade organization was responsible for assuring production quotas were met, and distribution was carried out accordingly after the breakup. Trade organizations such as the one regulating pharmaceuticals no longer existed, and a new solution needed to be put in place. Manufacturers did not know distributors, and distributors did not know manufacturers.